AAAAAA
Results:
1-14
|
Results: 14
Authors:
BROX AG
LARYEA H
PELLETIER M
Citation: Ag. Brox et al., SUCCESSFUL TREATMENT OF ACQUIRED FACTOR-VIII INHIBITORS WITH CYCLOSPORINE, American journal of hematology, 57(1), 1998, pp. 87-88
Authors:
BROX AG
MANGEL J
HANLEY JA
STLOUIS G
MONGRAIN S
GAGNON RF
Citation: Ag. Brox et al., ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION REPRESENTS AN ABNORMALITY OF INSULIN-LIKE GROWTH-FACTOR-I AND ITS BINDING-PROTEINS, Transplantation, 66(8), 1998, pp. 1053-1058
Authors:
GAGNON RF
YARED K
BARRE PA
BROX AG
Citation: Rf. Gagnon et al., SURVEY OF THE MANAGEMENT OF ANEMIA IN END-STAGE RENAL-DISEASE (ESRD), Journal of the American Society of Nephrology, 8, 1997, pp. 328-328
Authors:
GAGNON RF
YARED K
DUGUID WP
BROX AG
Citation: Rf. Gagnon et al., RENAL OSTEODYSTROPHY IN MICE WITH CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 2569-2569
Authors:
GAGNON RF
MATSELL D
YARED K
BROX AG
Citation: Rf. Gagnon et al., ALTERED HEPATIC PRODUCTION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-1) AND ITS BINDING-PROTEINS (IGFBP) IN EXPERIMENTAL CHRONIC-RENAL-FAILURE (CRF), Journal of the American Society of Nephrology, 8, 1997, pp. 2869-2869
Authors:
YARED K
GAGNON RF
BROX AG
Citation: K. Yared et al., MECHANISM OF ACTION OF ANDROGEN TREATMENT ON THE ANEMIA OF EXPERIMENTAL CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 2950-2950
Authors:
GAGNON RF
JONASCH E
VASILEVSKY M
BROX AG
Citation: Rf. Gagnon et al., ABSENCE OF SIGNIFICANT ANEMIA IN 2 DIALYSIS PATIENTS WITHOUT ERYTHROPOIETIN TREATMENT AND BLOOD-TRANSFUSIONS - POSSIBLE ROLE OF INSULIN-LIKE GROWTH-FACTOR-I IN THE MAINTENANCE OF ERYTHROPOIESIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1150-1150
Authors:
ZHANG F
LANEUVILLE P
GAGNON RF
MORIN B
BROX AG
Citation: F. Zhang et al., EFFECT OF CHRONIC-RENAL-FAILURE ON THE EXPRESSION OF ERYTHROPOIETIN MESSAGE IN A MURINE MODEL, Experimental hematology, 24(13), 1996, pp. 1469-1474
Authors:
BROX AG
ZHANG F
GUYDA H
GAGNON RF
Citation: Ag. Brox et al., SUBTHERAPEUTIC ERYTHROPOIETIN AND INSULIN-LIKE GROWTH-FACTOR-I CORRECT THE ANEMIA OF CHRONIC-RENAL-FAILURE IN THE MOUSE, Kidney international, 50(3), 1996, pp. 937-943
Authors:
ZHANG F
GAGNON RF
RICHARDS GK
BROX AG
Citation: F. Zhang et al., ANEMIA OF CHRONIC-RENAL-FAILURE - CHARACTERIZATION IN THE MOUSE AND CORRECTION WITH HUMAN RECOMBINANT ERYTHROPOIETIN, Nephron, 72(4), 1996, pp. 654-661
Authors:
JONASCH E
BROX AG
GAGNON RF
VASILEVSKY M
Citation: E. Jonasch et al., INSULIN-LIKE GROWTH-FACTOR-I (IGF-1), IGF1 BINDING-PROTEINS (BP1, BP3) AND ERYTHROPOIETIN (EPO) SERUM LEVELS IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 579-579
Authors:
BROX AG
GAGNON RF
Citation: Ag. Brox et Rf. Gagnon, TREATMENT OF MICE WITH INSULIN-LIKE GROWTH-FACTOR-I (IGF-1) COMBINED TO SUBTHERAPEUTIC ERYTHROPOIETIN (EPO) CORRECTS THE ANEMIA OF CHRONIC-RENAL-FAILURE (CRF), Journal of the American Society of Nephrology, 6(3), 1995, pp. 733-733
Authors:
BROX AG
GUYDA H
ZHANG F
GAGNON RF
LANEUVILLE P
Citation: Ag. Brox et al., REGULATION OF IGF-1 AND IGF-BINDING PROTEINS IN AN ANIMAL-MODEL OF ACUTE AND CHRONIC ANEMIA, Blood, 82(10), 1993, pp. 10000462-10000462
Authors:
ZHANG F
BROX AG
LANEUVILLE P
MORIN B
GAGNON RF
Citation: F. Zhang et al., EFFECT OF CHRONIC-RENAL-FAILURE (CRF) ON THE EXPRESSION OF ERYTHROPOIETIN (EPO) MESSAGE IN A MURINE MODEL, Blood, 82(10), 1993, pp. 10000507-10000507
Risultati:
1-14
|